A critique of intradiscal administration for treatment of radiculopathy [7]

Anesthesiology

Volumn 108, Issue 2, 2008, Pages 334-

  Tobinick, Edward L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT;

CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG EFFICACY; HUMAN; INTRADISCAL DRUG ADMINISTRATION; LETTER; PRIORITY JOURNAL; RADICULOPATHY;

EID: 38549096507     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000300072.56020.10     Document Type: Letter

References (14)

1. Cohen SP, Wenzell D, Hurley RW, Kurihara C, Buckenmaier CC III, Griffith S, Larkin TM, Dahl E, Morlando BJ: A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy. ANESTHESIOLOGY 2007; 107:99-105
2. Tobinick EL, Britschgi-Davoodifar S: Perispinal TNF-alpha inhibition for discogenic pain. Swiss Med Wkly 2003; 133:170-7
3. Tobinick E, Davoodifar S: Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: A study of clinical observations in 143 patients. Curr Med Res Opin 2004; 20:1075-85
4. Sommer C, Schafers M: Mechanisms of neuropathic pain: The role of cytokines. Drug Discovery Today Dis Mech 2004; 1:441-8
5. Aoki Y, Takahashi K, Ohtori S, Moriya H: Neuropathology of discogenic low back pain: A review. Internet J Spine Surg 2005; 2 (1)
6. Arden NK, Price C, Reading I, Stubbing J, Hazelgrove J, Dunne C, Michel M, Rogers P, Cooper C: A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: The WEST study. Rheumatology (Oxford) 2005; 44:1399-406
7. Tobinick E, Tobinick A, inventors; TACT IP, LLC, assignee: Tumor necrosis factor antagonists for the treatment of neurological disorders. US patent 6,015,557. January 18, 2000
8. Tobinick EL: Targeted etanercept for discogenic neck pain: Uncontrolled, open-label results in two adults. Clin Ther 2003; 25:1211-8
9. Tobinick E, inventor; TACT IP, LLC, assignee: Cytokine antagonists for the treatment of localized disorders. US patent 6,419,944. July 16, 2002
10. Tobinick E, inventor; TACT IP, LLC, assignee: Cytokine antagonists for treatment of localized disorders. US patent 6,537,549. March 25, 2003
11. Tobinick E, inventor; TACT IP, LLC, assignee: Cytokine antagonists for neurological and neuropsychiatric disorders. US patent 6,982,089. January 3, 2006
12. Tobinick E: Spinal delivery of p38: TNF-alpha inhibitors. PLoS Med 2006; 3:e511
13. Sommer C, Schafers M, Marziniak M, Toyka KV: Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst 2001; 6:67-72
14. Wacnik PW, Eikmeier LJ, Simone DA, Wilcox GL, Beitz AJ: Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice. Neuroscience 2005; 132:479-91